Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Milwaukee, Wisconsin


Purpose:

The objective of this trial was to assess subject preference for PARCOPA, carbidopa/levodopa Orally Disintegrating Tablets (ODT), compared with conventional carbidopa/levodopa tablets, in subjects with stable Parkinson's disease.


Study summary:

See approved Package Insert for Adverse Event information.


Criteria:

Inclusion Criteria: - Stable Parkinson's Disease Exclusion Criteria: - Not using carbidopa/levodopa tablets


NCT ID:

NCT00139867


Primary Contact:

Study Director
UCB Clinical Trial Call Center
UCB Pharma


Backup Contact:

N/A


Location Contact:

Milwaukee, Wisconsin
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.